Skip to main content

AMERIPRISE FINANCIAL INC

Position in WGS — GeneDx Holdings Corp.

CIK 820027 MINNEAPOLIS, MN

Position in WGS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,579,990
-$2,644,442 QoQ
Shares Held
195,889
+67.3% QoQ
Ownership
0.660%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 97.60782892352302.ToString("F0")% None 2.392171076476984.ToString("F0")%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$991,208
PutShares
9,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $3,145,181,729 across 32 Diagnostics & Research names. WGS ranks #20 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,579,990 195,889
2025-12-31 $15,224,432 117,057
2025-09-30 $991,208 9,200
2025-09-30 $19,723,637 183,067
2025-06-30 $23,624,988 255,931
2025-03-31 $12,863,798 145,247
2024-12-31 $2,644,522 34,407